Genetics of stroke

AbstractStroke is the second most common cause of death and the most common cause of disability in developed countries. Stroke is a multi-factorial disease caused by a combination of environmental and genetic factors. Numerous epidemiologic studies have documented a significant genetic component in the occurrence of strokes. Genes encoding products involved in lipid metabolism, thrombosis, and inflammation are believed to be potential genetic factors for stroke. Although a large group of candidate genes have been studied, most of the epidemiological results are conflicting. Studies of stroke as a monogenic disease have made huge progress, and animal models serve as an indispensable tool to dissect the complex genetics of stroke. In the present review, we provide insight into the role of in vivo stroke models for the study of stroke genetics.

[1]  J. Lau,et al.  Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. , 2008, Archives of internal medicine.

[2]  L. Smeeth,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Homocysteine and Stroke: Evidence on a Causal Link from Mendelian Randomisation , 2022 .

[3]  T. Nakayama,et al.  Polymorphism of the C-Reactive Protein (CRP) Gene Is Related to Serum CRP Level and Arterial Pulse Wave Velocity in Healthy Elderly Japanese , 2006, Hypertension Research.

[4]  J. Weisel,et al.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk , 2003, The Lancet.

[5]  J. Attia,et al.  Polymorphisms in Platelet Glycoprotein 1bα and Factor VII and Risk of Ischemic Stroke: A Meta-Analysis , 2008, Stroke.

[6]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[7]  Paola Sebastiani,et al.  Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia , 2005, Nature Genetics.

[8]  Kazuhiro Iwai,et al.  Cerebral vascular accumulation of Dutch‐type Aβ42, but not wild‐type Aβ42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type , 2007, Journal of neuroscience research.

[9]  T. Lumley,et al.  Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke , 2008, Pharmacogenetics and genomics.

[10]  J. Gulcher,et al.  PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden , 2007, Journal of the Neurological Sciences.

[11]  P. Rothwell,et al.  Heritability of Ischemic Stroke in Relation to Age, Vascular Risk Factors, and Subtypes of Incident Stroke in Population-Based Studies , 2004, Stroke.

[12]  W. Liang,et al.  Clinical and genetic features in a MELAS child with a 3271T>C mutation. , 2008, Pediatric neurology.

[13]  K. Kohara,et al.  MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study , 2003, Stroke.

[14]  S. Dimauro,et al.  A novel tRNAVal mitochondrial DNA mutation causing MELAS , 2008, Journal of the Neurological Sciences.

[15]  S. Warach,et al.  Interleukin-6 −174G/C Polymorphism and Ischemic Stroke: A Systematic Review , 2007, Stroke.

[16]  B. Bloem,et al.  Hereditary cerebral hemorrhage with amyloidosis-Dutch type , 2004, Neuroradiology.

[17]  B. Dallapiccola,et al.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification , 2007, Journal of Medical Genetics.

[18]  E. Topol,et al.  Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. , 2008, JAMA.

[19]  V. Thijs,et al.  Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. , 2007, Stroke.

[20]  P. Macfarlane,et al.  Biogerontology: Mechanisms and Interventions , 2007 .

[21]  Yibo Wang,et al.  Phosphodiesterase 4D gene polymorphism is associated with ischaemic and haemorrhagic stroke. , 2009, Clinical science.

[22]  V. Thijs,et al.  Association of Apolipoprotein E ϵ2 With White Matter Disease but Not With Microbleeds , 2007 .

[23]  M. Fornage,et al.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury , 2006, Human Genetics.

[24]  D. Su,et al.  New strategies for the prevention of stroke , 2010, Clinical and experimental pharmacology & physiology.

[25]  P. Koudstaal,et al.  Variation in the Estrogen Receptor &agr; Gene and Risk of Stroke: The Rotterdam Study , 2008, Stroke.

[26]  T. Lumley,et al.  Variation in 24 hemostatic genes and associations with non‐fatal myocardial infarction and ischemic stroke , 2007, Journal of thrombosis and haemostasis : JTH.

[27]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[28]  R. Scott,et al.  The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. , 2007, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[29]  O. Bang,et al.  Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. , 2007, Biochemical and biophysical research communications.

[30]  T. Nakayama,et al.  Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. , 2006, American journal of hypertension.

[31]  R. Sacco,et al.  Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes: The Northern Manhattan Prospective Cohort Study , 2002, Stroke.

[32]  K. Yoshikawa,et al.  Renin-angiotensin system gene polymorphism in Japanese stroke patients , 2003 .

[33]  H S Markus,et al.  Phosphodiesterase 4D Gene, Ischemic Stroke, and Asymptomatic Carotid Atherosclerosis , 2005, Stroke.

[34]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[35]  S. Tognazzo,et al.  A common mutation in the gene for coagulation factor XIII‐A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases , 2001, American journal of hematology.

[36]  L. Badimón,et al.  Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques , 2006, Stroke.

[37]  L. Walker,et al.  Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. , 1996, Stroke.

[38]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[39]  A. Karantanas,et al.  Alpha-1 Antichymotrypsin Gene Signal Peptide A/T Polymorphism and Primary Intracerebral Hemorrhage , 2008, European Neurology.

[40]  K. Au,et al.  A novel mutation (C271F) in the Notch3 gene in a Chinese man with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[41]  B. Nordestgaard,et al.  Promotor Polymorphisms in Leukotriene C4 Synthase and Risk of Ischemic Cerebrovascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[42]  J. Zeman,et al.  Mitochondrial diseases and ATPase defects of nuclear origin. , 2004, Biochimica et biophysica acta.

[43]  R. Adams,et al.  Stroke Prevention in Sickle Cell Disease (STOP) Study Guidelines for Transcranial Doppler Testing , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[44]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[45]  J. Caillaud,et al.  Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. , 1999, Circulation.

[46]  T. Meitinger,et al.  Genetic Variation in Members of the Leukotriene Biosynthesis Pathway Confer an Increased Risk of Ischemic Stroke: A Replication Study in Two Independent Populations , 2008, Stroke.

[47]  R. Desnick,et al.  High incidence of later-onset fabry disease revealed by newborn screening. , 2006, American journal of human genetics.

[48]  Chiou-Lian Lai,et al.  Association of Apolipoprotein E Polymorphism with Ischemic Stroke Subtypes in Taiwan , 2007, The Kaohsiung journal of medical sciences.

[49]  M. Tesařová,et al.  The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. , 2008, Biochimica et biophysica acta.

[50]  Mark Gurney,et al.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke , 2003, Nature Genetics.

[51]  Christoph Lange,et al.  Genomics and genome-wide association studies: an integrative approach to expression QTL mapping. , 2008, Genomics.

[52]  P. Kwok,et al.  Endothelial Nitric Oxide Synthase Polymorphism (−786T→C) and Increased Risk of Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage , 2008, Stroke.

[53]  E. Sigurdsson,et al.  Distinct properties of wild‐type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type , 2001, Journal of neurochemistry.

[54]  Albert R. Singleton,et al.  The genetics of ischaemic stroke , 2010, Journal of internal medicine.

[55]  S. Humphries,et al.  Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches , 2004, The Lancet Neurology.

[56]  S. Sandberg,et al.  Usefulness of factor V Leiden mutation testing in clinical practice , 2010, European Journal of Human Genetics.

[57]  M. Lai,et al.  4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. , 2003, The Journal of laboratory and clinical medicine.

[58]  Li-sheng Liu,et al.  A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients , 2009, Stroke.

[59]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[60]  M. Yamada.  Cerebral amyloid angiopathy and gene polymorphisms , 2004, Journal of the Neurological Sciences.

[61]  Byoung-Soo Shin,et al.  The paraoxonase gene polymorphism in stroke patients and lipid profile , 2008, Acta neurologica Scandinavica.

[62]  Yi-Chung Lee,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: Two novel mutations in the NOTCH3 gene in Chinese , 2006, Journal of the Neurological Sciences.

[63]  H. Markus,et al.  Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness , 2007, Stroke.

[64]  T. Miles,et al.  Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation. , 2009, The American journal of geriatric pharmacotherapy.

[65]  T. Tabira,et al.  Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis , 2003, Journal of the Neurological Sciences.

[66]  J. Krieger,et al.  Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. , 2007, American heart journal.

[67]  Ö. Us,et al.  Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke , 2006, Journal of Clinical Neuroscience.

[68]  Janice L Holton,et al.  Sporadic and Familial Cerebral Amyloid Angiopathies , 2002, Brain pathology.

[69]  Á. Chamorro,et al.  &agr;1-Antichymotrypsin Polymorphism: A Risk Factor for Hemorrhagic Stroke in Normotensive Subjects , 2001, Stroke.

[70]  Y. Tamam,et al.  Association of Apolipoprotein E Genotype and Cerebrovascular Disease Risk Factors in a Turkish Population , 2008, The International journal of neuroscience.

[71]  D. Garbossa,et al.  Interleukin 6 gene polymorphisms are not associated with aneurysmal subarachnoid haemorrhage in an Italian population , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[72]  S. Brand-Herrmann.  Where do we go for atherothrombotic disease genetics? , 2008, Stroke.

[73]  J. Lambert,et al.  New Insight Into the Association of Apolipoprotein E Genetic Variants With Carotid Plaques and Intima-Media Thickness , 2006, Stroke.

[74]  Á. Chamorro,et al.  The –174G/C Polymorphism of the Interleukin 6 Gene Is a Hallmark of Lacunar Stroke and Not Other Ischemic Stroke Phenotypes , 2005, Cerebrovascular Diseases.

[75]  C. Mannhalter,et al.  The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. , 2003, Thrombosis research.

[76]  F. Chapon,et al.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.

[77]  Kazuhiko Ishikawa,et al.  Salt sensitivity of Japanese from the viewpoint of gene polymorphism. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[78]  A. Manolescu,et al.  Genetic profile of ischemic cerebrovascular disease and carotid stenosis , 2008, Acta neurologica Scandinavica.

[79]  Paul M Ridker,et al.  Inflammation, C-reactive protein, and atherothrombosis. , 2008, The Journal of Periodontology.

[80]  M. Pepys,et al.  C-reactive protein and atherothrombosis. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[81]  R. Christopher,et al.  Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis , 2006, Journal of the Neurological Sciences.

[82]  A. Słowik,et al.  Coagulation Factor XIII VaI34Leu Polymorphism in Patients with Small Vessel Disease or Primary Intracerebral Hemorrhage , 2005, Cerebrovascular Diseases.

[83]  T. DeGraba,et al.  The genetics of cerebrovascular atherosclerosis. , 2002, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[84]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[85]  W. Almawi,et al.  Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. , 2007, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[86]  D. Ganten,et al.  Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease , 1996, Nature Genetics.

[87]  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[88]  E. Boerwinkle,et al.  Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. , 2007, Atherosclerosis.

[89]  S. Ganesh,et al.  Inflammatory system gene polymorphism and the risk of stroke: A case–control study in an Indian population , 2008, Brain Research Bulletin.

[90]  J. Hibbert,et al.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype , 2009, Genomics insights.

[91]  L. Weinehall,et al.  Estrogen Receptor Alpha Gene Polymorphisms and First-Ever Intracerebral Hemorrhage , 2007, Cerebrovascular Diseases.

[92]  J. Morrissey,et al.  Polyphosphate as a general procoagulant agent , 2008, Journal of thrombosis and haemostasis : JTH.

[93]  A. Hamsten,et al.  Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case–Control Studies Based on Independent Cohorts , 2005, Stroke.

[94]  P. Ridker,et al.  Intercellular Adhesion Molecule 1 (ICAM1) Lys56Met and Gly241Arg Gene Variants, Plasma-Soluble ICAM1 Concentrations, and Risk of Incident Cardiovascular Events in 23 014 Initially Healthy White Women , 2007, Stroke.

[95]  A. Tward,et al.  Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice , 2002, Circulation.

[96]  R. Flore,et al.  Synergistic Effect of −174 G/C Polymorphism of the Interleukin-6 Gene Promoter and 469 E/K Polymorphism of the Intercellular Adhesion Molecule-1 Gene in Italian Patients With History of Ischemic Stroke , 2003, Stroke.

[97]  Hua-guang Zheng,et al.  Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[98]  P. Slonimski,et al.  Yeast Cells Lacking the Mitochondrial Gene Encoding the ATP Synthase Subunit 6 Exhibit a Selective Loss of Complex IV and Unusual Mitochondrial Morphology* , 2007, Journal of Biological Chemistry.

[99]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[100]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[101]  A. Reiner,et al.  Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. , 2008, Atherosclerosis.

[102]  Wenli Sheng,et al.  Meta-Analysis of Genetic Studies from Journals Published in China of Ischemic Stroke in the Han Chinese Population , 2008, Cerebrovascular Diseases.

[103]  M. Woodward,et al.  APOE genotype, ethnicity, and the risk of cerebral hemorrhage , 2008, Neurology.

[104]  B. Stegmayr,et al.  Genetic polymorphisms in the renin–angiotensin system confer increased risk of stroke independently of blood pressure: a nested case–control study , 2008, Journal of hypertension.

[105]  K. Kohara,et al.  An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke. , 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[106]  A. Guekht,et al.  Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity , 2007, Journal of the Neurological Sciences.

[107]  N. Papanas,et al.  Apolipoprotein E and First-ever Ischaemic Stroke in Greek Hospitalized Patients , 2007, The Journal of international medical research.

[108]  S. Panico,et al.  A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. , 2003, Atherosclerosis.

[109]  Zhu Jin,et al.  Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population. , 2004, Acta pharmacologica Sinica.

[110]  Kenneth Rice,et al.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. , 2008, Atherosclerosis.

[111]  M. Houslay,et al.  PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. , 2003, The Biochemical journal.

[112]  M. Yamada,et al.  Association of neprilysin polymorphism with cerebral amyloid angiopathy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[113]  I. Day,et al.  Molecular pathogenesis of subarachnoid haemorrhage. , 2003, The international journal of biochemistry & cell biology.

[114]  P. Macfarlane,et al.  Genetic Variation in the Interleukin‐10 Gene Promoter and Risk of Coronary and Cerebrovascular Events , 2007, Annals of the New York Academy of Sciences.

[115]  Á. Chamorro,et al.  α1-Antichymotrypsin Polymorphism , 2001 .

[116]  S. Yusuf,et al.  Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[117]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[118]  F. Schmidt.  Meta-Analysis , 2008 .

[119]  C. Abnet,et al.  A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China , 2007, Journal of Epidemiology and Community Health.

[120]  C. Carlson,et al.  Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults , 2008, Thrombosis and Haemostasis.

[121]  A. Hofman,et al.  Polymorphisms of the renin–angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[122]  R. Roos,et al.  Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects , 1996, Brain pathology.

[123]  R. Scott,et al.  Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding. , 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[124]  A. Algra,et al.  Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. , 2008, Blood.

[125]  Robert D. Brown,et al.  Genetics of cerebrovascular disorders. , 2005, Mayo Clinic proceedings.

[126]  G. Özdemir,et al.  Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms , 2006, Acta neurologica Scandinavica.

[127]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[128]  Ş. Demirkaya,et al.  Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. , 2008, Clinical biochemistry.

[129]  Geoffrey Cloud,et al.  Evaluating the Genetic Component of Ischemic Stroke Subtypes: A Family History Study , 2003, Stroke.